Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Overview Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Companies Involved in Therapeutics Development Bristol-Myers Squibb Co Celltrion Inc ChemoCentryx Inc GlaxoSmithKline Plc Humanigen Inc InflaRx NV Nichi-Iko Pharmaceutical Co Ltd Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Drug Profiles abatacept - Drug Profile Product Description Mechanism Of Action R&D Progress avacopan - Drug Profile Product Description Mechanism Of Action R&D Progress HGEN-005 - Drug Profile Product Description Mechanism Of Action R&D Progress IFX-1 - Drug Profile Product Description Mechanism Of Action R&D Progress mepolizumab - Drug Profile Product Description Mechanism Of Action R&D Progress rituximab biosimilar - Drug Profile Product Description Mechanism Of Action R&D Progress rituximab biosimilar - Drug Profile Product Description Mechanism Of Action R&D Progress rituximab biosimilar - Drug Profile Product Description Mechanism Of Action R&D Progress rituximab biosimilar - Drug Profile Product Description Mechanism Of Action R&D Progress Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Dormant Projects Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Discontinued Products Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Product Development Milestones Featured News & Press Releases Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer

List of Tables Number of Products under Development for Granulomatosis with Polyangiitis (Wegener's Granulomatosis), H1 2019 Number of Products under Development by Companies, H1 2019 Products under Development by Companies, H1 2019 Number of Products by Stage and Target, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 Number of Products by Stage and Route of Administration, H1 2019 Number of Products by Stage and Molecule Type, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline by Bristol-Myers Squibb Co, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline by Celltrion Inc, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline by ChemoCentryx Inc, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline by GlaxoSmithKline Plc, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline by Humanigen Inc, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline by InflaRx NV, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Dormant Projects, H1 2019 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Discontinued Products, H1 2019List of Figures Number of Products under Development for Granulomatosis with Polyangiitis (Wegener's Granulomatosis), H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products by Targets, H1 2019 Number of Products by Stage and Targets, H1 2019 Number of Products by Mechanism of Actions, H1 2019 Number of Products by Stage and Mechanism of Actions, H1 2019 Number of Products by Routes of Administration, H1 2019 Number of Products by Stage and Routes of Administration, H1 2019 Number of Products by Molecule Types, H1 2019 Number of Products by Stage and Molecule Types, H1 2019

Bristol-Myers Squibb Co Celltrion Inc ChemoCentryx Inc GlaxoSmithKline Plc Humanigen Inc InflaRx NV Nichi-Iko Pharmaceutical Co Ltd